Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Jnana Therapeutics has raised $107.0M in total funding. The most recent round was Series C. The last funding was announced in November 2022.
Jnana Therapeutics's investors include RA Capital Management, AbbVie, Polaris Partners, Bain Capital Life Sciences, Versant Ventures.
Jnana Therapeutics is headquartered in Boston, United States.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Jnana Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Jnana Therapeutics — Funding & Investors." VCBacked, November 15, 2022, https://www.vcbacked.co/company/jnana-therapeutics. Accessed November 11, 2026.
VCBacked. (2022). Jnana Therapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/jnana-therapeutics
{{cite web |title=Jnana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/jnana-therapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Jnana Therapeutics? Request a listing update